Literature DB >> 15734053

Immunoprotective properties of transgenic plants expressing E2 glycoprotein from CSFV and cysteine protease from Fasciola hepatica.

Andrzej B Legocki1, Katarzyna Miedzinska, Magdalena Czaplińska, Andrzej Płucieniczak, Halina Wedrychowicz.   

Abstract

Immune responses were elicited in laboratory animals after oral vaccination by transgenic plants (lettuce and alfalfa) expressing the E2 glycoprotein of Classical Swine Fever Virus (CSFV) or cysteine protease from Fasciola hepatica. ELISA analyses demonstrated that the oral route is effective in inducing a specific antibody response against these antigens in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734053     DOI: 10.1016/j.vaccine.2004.11.015

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  In planta production of two peptides of the Classical Swine Fever Virus (CSFV) E2 glycoprotein fused to the coat protein of potato virus X.

Authors:  Gianpiero Marconi; Emidio Albertini; Pierluigi Barone; Francesca De Marchis; Chiara Lico; Carla Marusic; Domenico Rutili; Fabio Veronesi; Andrea Porceddu
Journal:  BMC Biotechnol       Date:  2006-06-22       Impact factor: 2.563

2.  Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.

Authors:  Malgorzata Kesik-Brodacka; Agnieszka Lipiec; Monika Kozak Ljunggren; Luiza Jedlina; Katarzyna Miedzinska; Magdalena Mikolajczak; Andrzej Plucienniczak; Andrzej B Legocki; Halina Wedrychowicz
Journal:  PLoS Negl Trop Dis       Date:  2017-03-23

Review 3.  Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?

Authors:  Christopher Concha; Raúl Cañas; Johan Macuer; María José Torres; Andrés A Herrada; Fabiola Jamett; Cristian Ibáñez
Journal:  Vaccines (Basel)       Date:  2017-05-30

Review 4.  Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview.

Authors:  Doreen Manuela Floss; Dieter Falkenburg; Udo Conrad
Journal:  Transgenic Res       Date:  2007-04-14       Impact factor: 2.788

5.  Alfalfa Plants (Medicago sativa L.) Expressing the 85B (MAP1609c) Antigen of Mycobacterium avium subsp. paratuberculosis Elicit Long-Lasting Immunity in Mice.

Authors:  Elizabeth Monreal-Escalante; Cristhian Sández-Robledo; Amalia León-Gallo; Virginie Roupie; Kris Huygen; Sawako Hori-Oshima; Mario Arce-Montoya; Sergio Rosales-Mendoza; Carlos Angulo
Journal:  Mol Biotechnol       Date:  2021-03-02       Impact factor: 2.695

Review 6.  Plant-based oral vaccines against zoonotic and non-zoonotic diseases.

Authors:  Naila Shahid; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2016-08-23       Impact factor: 9.803

7.  A Preliminary Study of a Lettuce-Based Edible Vaccine Expressing the Cysteine Proteinase of Fasciola hepatica for Fasciolosis Control in Livestock.

Authors:  Agnieszka Wesołowska; Monika Kozak Ljunggren; Luiza Jedlina; Katarzyna Basałaj; Andrzej Legocki; Halina Wedrychowicz; Małgorzata Kesik-Brodacka
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

8.  Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever.

Authors:  Richard C Laughlin; Rachel Madera; Yair Peres; Brian R Berquist; Lihua Wang; Sterling Buist; Yulia Burakova; Sreenath Palle; Chungwon J Chung; Max V Rasmussen; Erica Martel; David A Brake; John G Neilan; Sara D Lawhon; L Garry Adams; Jishu Shi; Sylvain Marcel
Journal:  Plant Biotechnol J       Date:  2018-08-10       Impact factor: 9.803

Review 9.  Plant production of veterinary vaccines and therapeutics.

Authors:  R W Hammond; L G Nemchinov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 10.  A cross talk between the immunization and edible vaccine: Current challenges and future prospects.

Authors:  Ankit Sahoo; Ashok Kumar Mandal; Khusbu Dwivedi; Vikas Kumar
Journal:  Life Sci       Date:  2020-08-26       Impact factor: 5.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.